Carisma Therapeutics to Present at Upcoming Healthcare Industry and Investor Conferences

On October 26, 2022 Carisma Therapeutics Inc., a clinical stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, reported that the company will present at two healthcare industry conferences and one investor conference in the fourth quarter of 2022 (Press release, Carisma Therapeutics, OCT 26, 2022, View Source [SID1234622440]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

Schedule Your 30 min Free Demo!

Recent Conferences:
The 2022 Cell & Gene Meeting on the Mesa
October 12, 2022 at 1:45 pm EST

Upcoming Conferences:
34th Annual Piper Sandler Healthcare Conference
November 29, 2022 at TBD EST

ESMO Immuno-Oncology Congress 2022
December 8, 2022 at 10:00 am EST

Use the contact form at the top or bottom of this page to book a free demo to 1stOncology™, an all inclusive cancer drug development intelligence platform from BioSeeker. The platform provides value in oncology for you in areas such as:

Target scouting
Indication selection & expansion
Combinatorial drug settings
Drug repositioning
First in class analysis
Compound cross over analysis
Competitive analysis
Pathway analysis

and much more...

1stOncology is recognized as a
Top 10 Global Pharma Analytic Provider

Continue your journey with 1stOncology by accessing our Free Leading Cancer Conference Whitepapers, signing up for our Free Weekly Newsletter and requesting a Free Demo to see how we can help you be 1st in Oncology!